1,2-diaminobenzene has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandes, R; Gomes, RS; Moreira, FTC; Sales, MGF | 1 |
| Bell-Loncella, ET; Clancy, R; Cutler, ML; Dorchak, J; Iida, J; Lu, Y; Purazo, ML; Shriver, CD; Slavik, J | 1 |
2 other study(ies) available for 1,2-diaminobenzene and Breast Cancer
| Article | Year |
|---|---|
Sensing CA 15-3 in point-of-care by electropolymerizing O-phenylenediamine (oPDA) on Au-screen printed electrodes.
Topics: Antibodies; Biosensing Techniques; Breast Neoplasms; Early Detection of Cancer; Electrochemical Techniques; Electrodes; Female; Gold; Humans; Limit of Detection; Liquid Biopsy; Mucin-1; Phenylenediamines; Point-of-Care Systems; Polymers | 2018 |
Inhibition of cancer cell growth by ruthenium complexes.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Female; Humans; Intercellular Signaling Peptides and Proteins; Phenylenediamines; Ruthenium | 2016 |